Related Experiment Video
Updated: Mar 19, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma
Jean-Charles Nault1, Shalini Datta2, Sandrine Imbeaud2
1Inserm, UMR-1162, Génomique fonctionnelle des Tumeurs solides, Equipe Labellisée Ligue Contre le Cancer, Paris, F-75010 France; Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine, Paris, France; Université Paris 13, Sorbonne Paris Cité, UFR SMBH, F-93000 Bobigny, France; Université Paris Diderot, F-75013 Paris; APHP, Hôpitaux Universitaires Paris - Seine Saint-Denis, Site Jean Verdier, Pôle d'Activité Cancérologique Spécialisée, Service d'Hépatologie, F-93143 Bondy, France.
Abstract:
Adeno-associated virus type 2 (AAV2) is a defective DNA virus that was previously considered to be non-pathogenic. We identified somatic AAV2 integration in a subset of 11 hepatocellular carcinomas (HCC) that mainly developed in normal liver without known etiology through recurrent insertional mutagenesis in cancer driver genes such as telomerase reverse transcriptase (TERT), cyclin A2 (CCNA2), cyclin E1 (CCNE1), tumor necrosis factor (ligand) superfamily, member 10 (TNFSF10), and lysine (K)-specific methyltransferase 2B (KMT2B).
Insights
Adeno-associated virus type 2 (AAV2) DNA integration was found in hepatocellular carcinoma (HCC) cases. This viral DNA insertional mutagenesis occurred in key cancer driver genes, suggesting a novel role for AAV2 in liver cancer development.
Area of Science:
- Hepatology
- Virology
- Oncology
Background:
- Adeno-associated virus type 2 (AAV2) is a defective DNA virus.
- AAV2 was previously considered non-pathogenic.
- Hepatocellular carcinoma (HCC) is a primary liver cancer.
Purpose of the Study:
- To investigate the potential role of AAV2 in the development of HCC.
- To identify if AAV2 integrates into the host genome in HCC cases.
Main Methods:
- Analysis of tumor samples from HCC patients.
- Detection of viral DNA integration using molecular techniques.
- Identification of host genes affected by viral insertion.
Main Results:
- Somatic AAV2 integration was identified in a subset of 11 HCC cases.
- Integrations were found in normal liver tissue without known predisposing factors.
- Recurrent insertional mutagenesis occurred in cancer driver genes including TERT, CCNA2, CCNE1, TNFSF10, and KMT2B.
Conclusions:
- Somatic AAV2 integration is associated with HCC development.
- AAV2 can act as an insertional mutagen in liver cancer.
- This finding suggests a novel pathogenic role for AAV2 in human cancer.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
09:13Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
Published on: October 24, 2016
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Hepatitis